XML 112 R101.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Revenue by Product) (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Revenue from External Customer [Line Items]        
Product sales $ 3,808.6 $ 3,591.8 $ 7,445.7 $ 7,004.1
Royalties and other revenues 110.9 154.0 239.5 314.0
Immunology        
Revenue from External Customer [Line Items]        
Product sales 1,149.5 1,016.6 2,275.4 2,058.9
IMMUNOGLOBULIN THERAPIES        
Revenue from External Customer [Line Items]        
Product sales 612.1 510.5 1,170.0 1,008.8
HEREDITARY ANGIOEDEMA        
Revenue from External Customer [Line Items]        
Product sales 365.2 333.9 734.0 700.0
BIO THERAPEUTICS        
Revenue from External Customer [Line Items]        
Product sales 172.2 172.2 371.4 350.1
Hematology        
Revenue from External Customer [Line Items]        
Product sales 951.0 964.6 1,903.6 1,835.5
HEMOPHILIA        
Revenue from External Customer [Line Items]        
Product sales 746.7 743.9 1,489.5 1,394.3
INHIBITOR THERAPIES        
Revenue from External Customer [Line Items]        
Product sales 204.3 220.7 414.1 441.2
Neuroscience        
Revenue from External Customer [Line Items]        
Product sales 693.7 635.4 1,438.4 1,288.7
VYVANSE        
Revenue from External Customer [Line Items]        
Product sales 556.0 518.2 1,184.8 1,081.9
ADDERALL XR        
Revenue from External Customer [Line Items]        
Product sales 79.8 71.4 155.8 136.3
MYDAYIS        
Revenue from External Customer [Line Items]        
Product sales 16.6 15.7 21.1 15.7
Other Neuroscience        
Revenue from External Customer [Line Items]        
Product sales 41.3 30.1 76.7 54.8
Genetic Diseases        
Revenue from External Customer [Line Items]        
Product sales 391.7 371.0 724.2 701.1
ELAPRASE        
Revenue from External Customer [Line Items]        
Product sales 176.5 161.0 294.9 301.6
REPLAGAL        
Revenue from External Customer [Line Items]        
Product sales 125.6 122.1 249.8 231.8
VPRIV        
Revenue from External Customer [Line Items]        
Product sales 89.6 87.9 179.5 167.7
Internal Medicine        
Revenue from External Customer [Line Items]        
Product sales 232.9 145.1 411.8 277.1
GATTEX/REVESTIVE        
Revenue from External Customer [Line Items]        
Product sales 133.5 75.3 229.7 144.3
NATPARA/NATPAR        
Revenue from External Customer [Line Items]        
Product sales 64.8 34.5 109.8 64.2
Other Internal Medicine        
Revenue from External Customer [Line Items]        
Product sales 34.6 35.3 72.3 68.6
Established Brands        
Revenue from External Customer [Line Items]        
Product sales 218.5 339.2 392.0 626.0
LIALDA/MEZAVANT        
Revenue from External Customer [Line Items]        
Product sales 105.9 207.8 167.9 382.9
PENTASA        
Revenue from External Customer [Line Items]        
Product sales 77.5 83.3 149.9 152.4
Other Established Brands        
Revenue from External Customer [Line Items]        
Product sales 35.1 48.1 74.2 90.7
Ophthalmics        
Revenue from External Customer [Line Items]        
Product sales 100.3 57.4 162.4 96.0
Oncology        
Revenue from External Customer [Line Items]        
Product sales 71.0 62.5 137.9 120.8
Royalties        
Revenue from External Customer [Line Items]        
Royalties and other revenues 59.7 113.2 130.3 218.3
Other revenues        
Revenue from External Customer [Line Items]        
Royalties and other revenues 51.2 40.8 109.2 95.7
United States        
Revenue from External Customer [Line Items]        
Product sales 2,450.2 2,375.1 4,805.2 4,659.9
United States | Immunology        
Revenue from External Customer [Line Items]        
Product sales 863.9 787.2 1,700.4 1,602.0
United States | IMMUNOGLOBULIN THERAPIES        
Revenue from External Customer [Line Items]        
Product sales 457.3 407.9 878.9 813.3
United States | HEREDITARY ANGIOEDEMA        
Revenue from External Customer [Line Items]        
Product sales 326.2 303.4 658.6 643.1
United States | BIO THERAPEUTICS        
Revenue from External Customer [Line Items]        
Product sales 80.4 75.9 162.9 145.6
United States | Hematology        
Revenue from External Customer [Line Items]        
Product sales 428.1 459.2 881.8 871.4
United States | HEMOPHILIA        
Revenue from External Customer [Line Items]        
Product sales 372.9 383.1 766.0 724.6
United States | INHIBITOR THERAPIES        
Revenue from External Customer [Line Items]        
Product sales 55.2 76.1 115.8 146.8
United States | Neuroscience        
Revenue from External Customer [Line Items]        
Product sales 583.2 548.2 1,217.9 1,117.6
United States | VYVANSE        
Revenue from External Customer [Line Items]        
Product sales 486.6 460.1 1,043.8 968.6
United States | ADDERALL XR        
Revenue from External Customer [Line Items]        
Product sales 75.7 67.2 147.8 126.5
United States | MYDAYIS        
Revenue from External Customer [Line Items]        
Product sales 16.6 15.7 21.1 15.7
United States | Other Neuroscience        
Revenue from External Customer [Line Items]        
Product sales 4.3 5.2 5.2 6.8
United States | Genetic Diseases        
Revenue from External Customer [Line Items]        
Product sales 82.0 77.1 159.7 150.8
United States | ELAPRASE        
Revenue from External Customer [Line Items]        
Product sales 43.8 39.8 84.8 78.0
United States | REPLAGAL        
Revenue from External Customer [Line Items]        
Product sales 0.0 0.0 0.0 0.0
United States | VPRIV        
Revenue from External Customer [Line Items]        
Product sales 38.2 37.3 74.9 72.8
United States | Internal Medicine        
Revenue from External Customer [Line Items]        
Product sales 180.2 98.5 304.4 185.4
United States | GATTEX/REVESTIVE        
Revenue from External Customer [Line Items]        
Product sales 117.6 63.7 198.0 120.7
United States | NATPARA/NATPAR        
Revenue from External Customer [Line Items]        
Product sales 62.4 34.5 105.6 64.1
United States | Other Internal Medicine        
Revenue from External Customer [Line Items]        
Product sales 0.2 0.3 0.8 0.6
United States | Established Brands        
Revenue from External Customer [Line Items]        
Product sales 165.7 301.7 288.9 548.6
United States | LIALDA/MEZAVANT        
Revenue from External Customer [Line Items]        
Product sales 75.4 187.5 105.9 340.6
United States | PENTASA        
Revenue from External Customer [Line Items]        
Product sales 77.5 83.3 149.9 152.4
United States | Other Established Brands        
Revenue from External Customer [Line Items]        
Product sales 12.8 30.9 33.1 55.6
United States | Ophthalmics        
Revenue from External Customer [Line Items]        
Product sales 99.2 57.4 160.8 96.0
United States | Oncology        
Revenue from External Customer [Line Items]        
Product sales 47.9 45.8 91.3 88.1
International        
Revenue from External Customer [Line Items]        
Product sales 1,358.4 1,216.7 2,640.5 2,344.2
International | Immunology        
Revenue from External Customer [Line Items]        
Product sales 285.6 229.4 575.0 456.9
International | IMMUNOGLOBULIN THERAPIES        
Revenue from External Customer [Line Items]        
Product sales 154.8 102.6 291.1 195.5
International | HEREDITARY ANGIOEDEMA        
Revenue from External Customer [Line Items]        
Product sales 39.0 30.5 75.4 56.9
International | BIO THERAPEUTICS        
Revenue from External Customer [Line Items]        
Product sales 91.8 96.3 208.5 204.5
International | Hematology        
Revenue from External Customer [Line Items]        
Product sales 522.9 505.4 1,021.8 964.1
International | HEMOPHILIA        
Revenue from External Customer [Line Items]        
Product sales 373.8 360.8 723.5 669.7
International | INHIBITOR THERAPIES        
Revenue from External Customer [Line Items]        
Product sales 149.1 144.6 298.3 294.4
International | Neuroscience        
Revenue from External Customer [Line Items]        
Product sales 110.5 87.2 220.5 171.1
International | VYVANSE        
Revenue from External Customer [Line Items]        
Product sales 69.4 58.1 141.0 113.3
International | ADDERALL XR        
Revenue from External Customer [Line Items]        
Product sales 4.1 4.2 8.0 9.8
International | MYDAYIS        
Revenue from External Customer [Line Items]        
Product sales 0.0 0.0 0.0 0.0
International | Other Neuroscience        
Revenue from External Customer [Line Items]        
Product sales 37.0 24.9 71.5 48.0
International | Genetic Diseases        
Revenue from External Customer [Line Items]        
Product sales 309.7 293.9 564.5 550.3
International | ELAPRASE        
Revenue from External Customer [Line Items]        
Product sales 132.7 121.2 210.1 223.6
International | REPLAGAL        
Revenue from External Customer [Line Items]        
Product sales 125.6 122.1 249.8 231.8
International | VPRIV        
Revenue from External Customer [Line Items]        
Product sales 51.4 50.6 104.6 94.9
International | Internal Medicine        
Revenue from External Customer [Line Items]        
Product sales 52.7 46.6 107.4 91.7
International | GATTEX/REVESTIVE        
Revenue from External Customer [Line Items]        
Product sales 15.9 11.6 31.7 23.6
International | NATPARA/NATPAR        
Revenue from External Customer [Line Items]        
Product sales 2.4 0.0 4.2 0.1
International | Other Internal Medicine        
Revenue from External Customer [Line Items]        
Product sales 34.4 35.0 71.5 68.0
International | Established Brands        
Revenue from External Customer [Line Items]        
Product sales 52.8 37.5 103.1 77.4
International | LIALDA/MEZAVANT        
Revenue from External Customer [Line Items]        
Product sales 30.5 20.3 62.0 42.3
International | PENTASA        
Revenue from External Customer [Line Items]        
Product sales 0.0 0.0 0.0 0.0
International | Other Established Brands        
Revenue from External Customer [Line Items]        
Product sales 22.3 17.2 41.1 35.1
International | Ophthalmics        
Revenue from External Customer [Line Items]        
Product sales 1.1 0.0 1.6 0.0
International | Oncology        
Revenue from External Customer [Line Items]        
Product sales $ 23.1 $ 16.7 $ 46.6 $ 32.7